Signaling pathways upregulated leading to breast cancer include human epidermal growth factor receptor 2 (HER-2) tyrosine kinase pathway, a member of the ErbB family of transmembrane receptor tyrosine kinases [5]. Here, ERBB2 is linked to breast carcinoma.